No products in the cart.
Ozempic Semaglutide Injection wholesale – 1.5ml Pre-filled Pen – For Laboratory Research Only
$1.00
Ozempic Semaglutide Injection delivers 1.34mg/ml in a 1.5ml pre-filled pen (no needle included). Manufactured by Novo Nordisk. NMPA SJ20210014. For research use only. Wholesale and retail available.?For wholesale prices, other specifications and uses, please consult our staff?
Description
Semaglutide is a GLP-1 receptor agonist used in research for its role in glucose regulation, appetite control, and weight loss mechanisms. It mimics endogenous incretin hormones to stimulate insulin secretion and reduce glucagon levels.
This product features 1.5ml at 1.34mg/ml concentration, provided in a pre-filled pen (needle not included). It is ideal for research models investigating type 2 diabetes, obesity, and metabolic syndrome.
Manufactured by Novo Nordisk (Denmark) with Chinese NMPA approval number SJ20210014 and national drug code 86983568000012.
Ozempic Semaglutide Product Specifications
| Parameter | Details |
|---|---|
| Product Name | Semaglutide Injection Ozempic |
| Generic Name | Semaglutide |
| CAS Number | 910463-68-2 |
| Molecular Formula | C187H291N45O59 |
| Molecular Weight | ~4113.58 g/mol |
| Dosage Form | Injection (Pre-filled Pen) |
| Strength | 1.34mg/ml |
| Volume | 1.5ml |
| Total Semaglutide | ~2.01mg per pen |
| Approval Number | SJ20210014 (China NMPA) |
| Product Code | 86983568000012 |
| Manufacturer | Novo Nordisk, Denmark |
| Barcode | (Pending / Not Recorded) |
| Intended Use | For laboratory research only |
| Storage Conditions | Store refrigerated (2–8°C). Do not freeze. Protect from light. |
Ozempic Semaglutide Mechanism of Action & Research Applications
Semaglutide binds to the GLP-1 receptor, enhancing glucose-dependent insulin secretion, decreasing glucagon secretion, slowing gastric emptying, and reducing food intake.
Key Research Applications:
Type 2 diabetes models
Obesity and metabolic syndrome studies
Appetite and satiety signaling research
Weight loss efficacy studies
Incretin biology and receptor pharmacology
Ozempic Semaglutide Observed Side Effects (In Research Settings)
Nausea or gastrointestinal upset
Reduced appetite and weight loss
Injection site irritation
Mild hypoglycemia (in combination models)
Headache or dizziness
Safety & Handling Instructions
Use restriction: For laboratory research only.
Protective gear: Wear gloves, eye protection, and lab coat.
Storage: Refrigerate at 2–8°C. Do not freeze.
Disposal: Follow lab protocols and environmental regulations.
Research Use Disclaimer
This product is strictly intended for laboratory research use only. It is not approved for human or veterinary use, diagnosis, or treatment. Misuse may pose health and legal risks. Follow all institutional safety guidelines and protocols.
Additional information
| Weight | 1 kg |
|---|---|
| Dimensions | 36 × 32 × 36 cm |
Q1: Is this product safe for human or veterinary use?
A1: No. This product is intended strictly for research purposes only.
Q2: Is this equivalent to Ozempic used clinically?
A2: Yes, it is the same active pharmaceutical ingredient, but this version is for research use only.
Q3: Can I order in bulk for institutional use?
A3: Yes. Both wholesale and retail orders are supported.
Q4: Do you provide documentation such as COA or SDS?
A4: Yes, COA (Certificate of Analysis) and SDS (Safety Data Sheet) are available on request.
Q5: Does this product require cold chain shipping?
A5: Yes. It must be kept refrigerated during transport to ensure stability.
Q6: What organisms are suitable for semaglutide research?
A6: Most commonly mouse, rat, and primate models are used in metabolic studies.
Q7: Is the needle included with the pre-filled pen?
A7: No, needles are not included in this packaging.
Q8: What is the total dosage in one pen?
A8: Each pen contains approximately 2.01mg of semaglutide.
Q9: How does semaglutide aid in weight loss research?
A9: It activates the GLP-1 receptor, reducing appetite and increasing satiety in research models.
Q10: Is this identical to Wegovy?
A10: While Ozempic and Wegovy both contain semaglutide, they differ in dosing and indications. This product is intended solely for research.
Related products
Glibenclamide Tablets 2.5mg × 100 Tablets – For Laboratory Research Use Only
Glibenclamide Tablets (2.5mg) are oral hypoglycemic agents commonly studied in glucose regulation, pancreatic beta-cell response, and Type 2 diabetes models. Supplied as 100 tablets per bottle. For research use only.?Please consult staff for price, other specifications and uses? $3.00Empagliflozin Tablets 10mg (Koltangen) – For Research Use Only
Empagliflozin Tablets (10mg) for research use only. Used in experimental studies on SGLT2 inhibition, glucose excretion, and type 2 diabetes models. Manufactured by Sichuan Kelun Pharmaceutical Co., Ltd.?For wholesale prices, other specifications and uses, please consult our staff?
$1.00Glipizide Tablets
Pure Glipizide 5mg film-coated tablets, 30-count box, manufactured by Hainan Zanbang Pharmaceutical Co., Ltd. Trusted for laboratory research on sulfonylurea mechanisms and antidiabetic studies.
For laboratory research or analytical purposes only – Not for human consumption or therapeutic use. $3.00Epalrestat Tablets 50mg – For Laboratory Research Use Only
Epalrestat Tablets provide 50mg of active compound per tablet. Manufactured by Hebei Ruisen Pharmaceutical Co., Ltd. Approved under H20253680. Intended strictly for laboratory research use only. Supports both bulk and individual orders.?For wholesale prices, other specifications and uses, please consult our staff?
$2.00
Reviews
There are no reviews yet.